A new project is working on improving scalp cooling technology that prevents hair loss in cancer patients.
Findings show benefits compared with FOLFIRI for patients with untreated metastatic disease.
A new technique to treat retinoblastoma may help prevent eye loss, blindness, or death in children with advanced forms of the disease.
Herceptin in addition to chemotherapy boosts survival, reduces risk of cancer recurrence
Recommended safe handling practices for workers who administer antineoplastic drugs in health care settings are not always followed, according to a new study.
Legislation passed in 2003 intended to slow the spiraling costs of drugs paid for by the federal government to treat Medicare patients has not proved to be a success.
The first direct comparison of treating nonsquamous lung cancer with either pemetrexed or docetaxel in addition to cisplatin has shown that the two combinations achieve similar progression-free survival.
Is sequencing important when administering chemotherapy on the same day?
Treatnent with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to phase II trial data.
Addition of the experimental drug cediranib to standard chemotherapy improves tumor shrinkage and adds a modest improvement in progression-free survival for patients with cervical cancer that has recurred after treatment.
After failure of platinum-based chemotherapy, the tyrosine kinase inhibitor (TKI) afatinib significantly improved progression-free survival in patients with recurrent or metastatic squamous cell carcinoma of the head and neck.
A number of oncologists hesitate to administer treatments to pregnant patients with cancer, due to concerns about the effect on the unborn.
Akynzeo approved for the treatment chemotherapy-induced nausea and vomiting (CINV) in patients with cancer.
Can vitamins or supplements help address hair loss caused by cancer therapy?
The monoclonal antibody nivolumab has demonstrated superior response and duration over standard chemotherapy in patients whose melanoma has progressed after ipilimumab treatment.
For younger patients with an acute lymphoblastic leukemia (ALL) subtype, modifying treatment based on chemotherapy response can make a vital difference.
A combination of exercise with chemotherapy shrunk tumors more than employing chemotherapy alone, according to research performed with a melanoma model.
Combination therapy with both BRAF inhibitor vemurafenib and MEK inhibitor cobimetinib achieved superior results over vemurafenib plus placebo for BRAF-mutation positive melanoma.
Managing toxicity costs are higher for treatment with less-specific targeted agents and chemotherapies.
Exposure to dim light at night may make breast tumors resistant to chemotherapy
Adding carboplatin and/or bevacizumab to the standard treatment regimen significantly improved pathologic complete response rates in patients with triple-negative breast cancer, according to a new phase 2 study.
Radiation therapy with concurrent paclitaxel chemotherapy after surgery can be effective to treat patients with high-risk endometrial cancer, according to new research.
Chokeberry extract enhances cytotoxicity of gemcitabine on a single cancer cell line, according to research.
The addition of chest radiation reduces recurrence rate and, improves survival when added to chemo in extensive stage small-cell lung cancer.
Is there any benefit to half-strength chemotherapy given to patients experiencing side effects from the drug or due to decreased functional status?
Could a medication indicated for nausea and vomiting in pregnancy resolve the same symptoms in patients undergoing chemotherapy?
Vaccine is effective even among older adults who subsequently undergo chemotherapy.
The herpes zoster vaccine continues to be effective in protecting older adults against shingles, even after they undergo chemotherapy, according to a recent study.
A 10-year study shows that increased availability of better systemic chemotherapies and targeted therapies for patients with advanced non-small cell lung cancer coincides with increased usage of these therapies.
Changes in how follicular lymphoma is managed have led to substantial improvement in prognosis and over all survival for patients with the disease.
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|